Cyto-Facto
Minamimachi
About Cyto-Facto
Cyto-Facto specializes in the contract development and manufacturing of cell and gene therapy products. The company offers services encompassing process development, GMP manufacturing, and quality control testing. Their digital platform enhances manufacturing efficiency through RFID tracking and paperless operations.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $7.6M
- Funding stage: Early Stage Venture
- Last round: Series A (Apr 2024)
- Website: cytofacto.com
Industries & Categories
Biotechnology, Manufacturing, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/cyto-facto-66320 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.